{
    "Orphapacket": {
        "ORPHApacketId": "206575",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "206575",
        "Label": "Rippling muscle disease with myasthenia gravis",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_206575",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Acquired rippling muscle disease"
            },
            {
                "Synonym": "Immune-mediated rippling muscle disease"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Rippling muscle disease with myasthenia gravis is a rare acquired neuromuscular disease characterized by <i>CAV3</i> mutation-negative rippling muscle disease in association with acetylcholine receptor antibody-mediated myasthenia gravis. Patients typically present exercise-induced electrically-silent muscle rippling with myalgia in combination with generalized myasthenia gravis symptoms (ptosis diplopia neck weakness dysphagia and dyspnea)."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "464764",
                        "Label": "Immune-mediated acquired neuromuscular junction disease"
                    }
                ]
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}